课题基金 / 基金详情

Growth and differentiation signals of the erythropoietin receptor

Growth and differentiation signals of the erythropoietin receptor
促红细胞生成素受体的生长和分化信号
批准号:
09470036
负责人:
YOSHIMURA Akihiko
金额:
$8.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

YOSHIMURA Akihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To identify the novel substrate of c-kit which is important for hematopoietic stem cell self-renewal or differentiation, CD34-negative, Sca-1 positive, c-KIT-positive, and Lineage marker-negative (CD34-Sca-1+c-Kit-Lin- )cells were sorted by a fluorescence-activated cell sorter from mouse and two hybrid cDNA library was constructed. By the screening using c-kit as bait, we cloned a novel cDNA, designed STAP-1, encoding an adaptor protein with a Pleckstrin homology domain, Src homology 2 domain, and a number of tyrosine phosphorylation sites. RT-PCR analysis revealed that STAP-1 expression is restricted in bone marrow cell fraction expressing c-kit, and the highest expression was observed in CD34-Sca-1+c-Kit+Lin- hematopietic stem cell enriched fraction. Murine myeloid cell line, M1 expressed high level of STAP-1. However, the expression was strongly repressed in response to leukemia inhibitory factor which induced monocytic differentiation of M1 cells, suggesting that STAP-1 is associat … More ed with undifferentiated cell type. In 293 cells, STAP-1 was tyrosine phosphorylated by activated c-kit. In vitro binding assay suggested that STAP-1 SH2 domain interacted with several tyrosine phosphorylated proteins including c-kit and STAT5.There suggest that STAP-1 functions as an adaptor molecule downstream of c-kit in hematopoietic stem cells.CIS3/SOC53 are small SH2 containing proteins that interact with and inhibit JAK tyrosine kinases. During embryonic development, CIS53/SOCS-3 is highly expressed in some but no all erythroid lineage cells of the fetal liver and this expression is independent of erythropoietin (EPO) signaling. Transgene mediated constitutive expression blocks fetal erythropoiesis resulting in an embryonic lethality. Deletion of CIS3/SOCS-3 results in an embryonic lethality at 12-16 days that is associated with a marked erythrocytosis. Moreover, the individual in vitro proliferative capacity of fetal liver progenitors is greatly increased. The results demonstrate that CIS3/SOCS-3 play a critical role in negatively regulating fetal liver hematopoiesis. We also demonstrated that CIS3-SOCS3 bound to the EPO receptor as well as JAK2 in erythroid progenitors from spleen and Ba/F3 cells expressing the EPOR (BF-ER), suggesting a specific negative regulatory effect of CIS3/SOCS3 on EPO signaling. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasukawa H, et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18, 5. 1309-1320 (1999)
Yasukawa H 等人:“JAK 结合蛋白 JAB 通过与激活环中的结合抑制 Janus 酪氨酸激酶活性。”EMBO J.. 18, 5. 1309-1320 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wakioka T,et al.: "APS,an Adaptor Protein Containing PH and SH2 Domains Inhibits the JAK-STAT Pathway in Collaboration with c-Chl" Leukemia. in press. (1999)
Wakioka T 等人:“APS,一种含有 PH 和 SH2 结构域的接头蛋白,与 c-Chl 协同抑制 JAK-STAT 通路”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Immune systems involved in the resolution of inflammation and tissue repair
  • 批准号:
    17H06175
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
  • 资助金额:
    $131.71万
  • 财政年份:
    2017
  • 负责人:
    YOSHIMURA Akihiko
  • 依托单位:
Identification of Cellular Signaling Mechanism that regulates inflammation and tissue repairing
  • 批准号:
    25221305
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
  • 资助金额:
    $122.8万
  • 财政年份:
    2013
  • 负责人:
    YOSHIMURA Akihiko
  • 依托单位:
Systemic Biology of T cell differentiation
  • 批准号:
    25670234
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2013
  • 负责人:
    YOSHIMURA Akihiko
  • 依托单位:
Systembiology of T-cell differentiation
  • 批准号:
    23659242
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2011
  • 负责人:
    YOSHIMURA Akihiko
  • 依托单位:
国内基金
海外基金
基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
  • 批准号:
    2026JJ82274
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    侯凯
  • 依托单位:
SIRT6通过去乙酰化修饰调控JAK2/STAT1信号通路介导细胞焦亡途径促进脊髓损伤进展的分子机制研究
  • 批准号:
    2026JJ81836
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈朝晖
  • 依托单位:
黄芪多糖调控JAK2/STAT3信号通路抵抗PD-L1介导的卵巢癌细胞免疫逃逸研究
益气活血方调控雪旺细胞外泌体/JAK2/STAT3通路介导巨噬细胞极化改善糖尿病足溃疡的作用机制研究
  • 批准号:
    2026JJ80487
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    于洪海
  • 依托单位: